Guides No. 29 - Best Practice in the Application of Biomarkers of Exposure as Compliance Measures in Long-Term and Epidemiological Studies of New Nicotine and Tobacco Products April 2024 Ref. BMK-362-CTG-29
Reports Population estimates of biomarkers of exposure to carbon monoxide, nicotine, and NNK in smokers and non-smokers BMK - Published in Qeios - March 2022 November 2022 Ref. BMK-249-2-CXP
Reports Assessing Product Use Behaviour and Exposure: Definitions and Methods PUB / BMK Technical Report October 2022 Ref. PUB-BMK-273-1-CTR
Reports Review of recent lung biomarkers of potential harm/effect for tobacco research BMK - Published in F1000Research 2021, 10:1293 December 2021 Ref. BMK-161-2-CXP
Guides No. 20 - Biomarker Studies - Requirements for the Certification of Analytical Reference Standards July 2021 - second edition Ref. BMK-307-CTG-20
Reports Review of Recent Lung Biomarkers of Potential Harm/Effect for Tobacco Research BMK Technical Report September 2020 Ref. BMK-161-1-CTR
Reports Meta-Analysis Study to Establish Baseline Levels of COHb and NEQs in Smokers and Non-Smokers BMK Technical Report December 2019 Ref. BMK-186-1-CTR
Reports Inter-Laboratory Comparison Test Measuring Total NNAL in Human Urine BMK Technical Report November 2018 Ref. BMK-092-CTR
Reports An Inter-Laboratory Comparison for the Urinary Acrolein Biomarker 3-Hydroxypropyl-Mercapturic Acid (3-HPMA) BMK - Published in Beiträge zur Tabakforschung International/Contributions to Tobacco Research - Volume 27, No. 5 January 2017 Ref. BMK-093-2-CXP
Reports 3-HPMA Interlaboratory Comparison Study 2012 BMK Technical Report July 2016 Ref. BMK-093-1-CTR